Addressing glycaemic variation

British Journal of Diabetes and Vascular Disease

Volumn 11, Issue 1, 2011, Pages 2-5

  Seufert, Jochen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

complications; diabetes; glycaemic variability hypoglycaemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK ASSESSMENT; SELF MONITORING;

EID: 79952562448     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651410377553     Document Type: Article

References (24)

1. Nathan DM, Turgeon H., Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007 ; 50: 2239-44. (Pubitemid 47512407)
2. DCCT Research Group. The relationship of glycaemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995 ; 44: 968-83.
3. Ryden L., Standl E., Bartnik M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular disease. Eur Heart J 2007 ; 28: 88-136.
4. International Diabetes Federation Clinical Guidelines Task Force. Global guideline for type-2 diabetes. www.idf.org (last accessed 20 May 2010.
5. Riddle MC Evening insulin strategy. Diabetes Care 1990 ; 13: 676-86. (Pubitemid 20169147)
6. UKPDS Study Group. Intensive blood-glucose control with sulphonyl-ureas or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes (UKPDS 33). Lancet 1998 ; 352: 837-53.
7. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in people with type-2 diabetes. N Engl J Med 2008 ; 358: 2560-72.
8. ACCORD Study Group. Effectiveness of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 ; 358: 2545-59.
9. Duckworth W., Abraira C., Moritz T. et al. Glucose control and vascular complications in veterans with type-2 diabetes. N Engl J Med 2009 ; 360: 129-39.
10. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 ; 359: 1577-89.
11. Monnier L., Mas E., Ginet C. et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycaemia in patients with type-2 diabetes. JAMA 2006 ; 295: 1681-87.
12. Hilsted J. Cardiovascular changes during hypoglycaemia. Clin Physiol 1993 ; 13: 1-10. (Pubitemid 23048726)
13. Avogaro A., Vigili de Kreutzenberg S., Negut C. et al. Diabetic cardiomyopathy: a metabolic perspective. Am J Cardiol 2004 ; 93: 13A - 16A. (Pubitemid 38496365)
14. Landstedt-Hallin L., Englund A., Adamson U. et al. Increased QT dispersion during hypoglycaemia in patients with type-2 diabetes mellitus. J Intern Med 1999 ; 246: 299-307. (Pubitemid 29426449)
15. Miller DR, Finke G., Lafrance J-P. et al. Hypoglycaemia and the risk of myocardial infarction in US veterans with diabetes. Diabetologia 2009 ; 52 [ Suppl.1 ]: S63.
16. Pinto DS, Skolnick AH, Kirtaine AJ et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005 ; 1: 178-83.
17. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet 1999 ; 354: 617-21.
18. Hanefeld M., Fischer S., Julius U. et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996 ; 39: 1577-83. (Pubitemid 26397370)
19. Cerriello A., Davidson J., Hanefeld M. et al. Postprandial hyperglycaemia and cardiovascular complications of diabetes. Nutr Metab Cardiovasc Dis 2006 ; 16: 453-6.
20. Monnier L., Colette C., Dunseath GJ The loss of postprandial glycaemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007 ; 30: 263-9. (Pubitemid 46198328)
21. Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycaemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003 ; 26: 881-5. (Pubitemid 36929359)
22. Zaccardi F., Pitocco D., Ghirlanda G. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009 ; 25: 199-207.
23. Monnier L., Collete C. Glycemic variability: should we and can we prevent it? Diabetes Care 2008 ; 31 Suppl 2: S150-4.
24. Kilpatrick ES, Rigby AS, Atkin SL Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009 ; 32: 1901-1903.